Pricing Log in Create free account

Taysha Gene Therapies, Inc. (TSHA) vs Vor Biopharma Inc. (VOR)

Taysha Gene Therapies, Inc. and Vor Biopharma Inc. are both Biotechnology companies. Taysha Gene Therapies, Inc. and Vor Biopharma Inc. are of similar size ($1.2B and $1.1B). Across the 10 metrics below, Taysha Gene Therapies, Inc. leads on 7 and Vor Biopharma Inc. on 3.

Valuation

Metric TSHA VOR Biotechnology median
P/E n/m n/m 8.50
P/S 113.26 n/m 9.71
P/B 3.45 6.97 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 78.83 n/m 9.21
Earnings yield (11.60%) (2,102.61%) (33.15%)
Free cash flow yield (10.41%) (7.76%) (25.50%)

Profitability

Metric TSHA VOR Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.05%) (69.27%) (56.36%)
Return on assets (37.23%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TSHA VOR Biotechnology median
Revenue growth (TTM) 18.96% — 6.02%
EPS growth (last fiscal year) 5.56% (107.35%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TSHA VOR Biotechnology median
Debt to equity 0.13 0.21 0.00
Current ratio 17.76 10.69 4.72
Net debt to EBITDA 2.47 2.27 0.96

Dividend

Metric TSHA VOR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TSHA VOR Biotechnology median
Market cap 1.22b 1.14b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack